Company intelligence / Profile preview

Holobeam Technologies

Hicksville, New York, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Holobeam is developing holographic medical imaging and therapeutic devices based on its patented Holographic Energy Teleportation (HET) technology for early cancer detection and localized energy delivery to tumors; the technology is described as having promising preclinical results but there are no registered clinical trials or marketed products yet.[3][5]

Therapeutic areas: Oncology
Modalities: DeviceNon-pharmacological therapy
Industry: Medical Imaging

Partnerships

Statera Biopharma (strategic alliance via memorandum of understanding to combine Holobeam’s early cancer detection with Statera’s immunotherapies)[3]

Beyond the preview

Go deeper on Holobeam Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Holobeam Technologies.

Explore the full profile